[BRIEFING.COM] The major averages are little changed over the past half hour as sector strngth remains splt, with tech and mega-cap names among the laggards.
EndPoint News reports that Eli Lilly (LLY 899.20, +2.67, +0.30%) and Novo Nordisk A/S (NVO 49.02, -0.09, -0.18%) will soon announce new drug pricing deals with the White House. The health care sector (+0.3%) holds a modest gain today, supported by strength in Waters (WAT 377.70, +32.12, +9.29%) and Henry Schein (HSIC 69.69, +5.05, +7.81%) after topping earnings estimates.
While not an S&P 500 component, Hims & Hers Health (HIMS 46.14, +1.75, +3.94%) holds a nice gain despite missing EPS expectations by $0.03, beating revenue expectations, and guiding Q4 revenues below consensus.